Reaction
Parotitis reporting signals
As of the last recalculation, Parotitis appears in 1,149 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 36.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 19 | 36.6 | 36.7 |
| Umeclidinium | 15 | 30.7 | 30.8 |
| Fluticasone Furoate | 17 | 25.8 | 25.8 |
| Dicyclomine Hydrochloride | 17 | 21.9 | 21.9 |
| Methimazole | 8 | 18.6 | 18.6 |
| Alemtuzumab | 19 | 18.1 | 18.1 |
| Octreotide Acetate | 28 | 16.9 | 17.0 |
| Haloperidol | 22 | 16.7 | 16.7 |
| Haloperidol Lactate | 22 | 16.4 | 16.4 |
| Fesoterodine Fumarate | 8 | 13.5 | 13.5 |
| Baricitinib | 7 | 13.2 | 13.2 |
| Fludarabine Phosphate | 25 | 11.8 | 11.8 |
| Posaconazole Delayed-Release | 7 | 11.6 | 11.6 |
| Anakinra | 10 | 11.0 | 11.0 |
| Sevoflurane | 4 | 8.7 | 8.7 |
| Ixazomib | 13 | 8.3 | 8.3 |
| Iohexol | 3 | 6.6 | 6.6 |
| Axicabtagene Ciloleucel | 3 | 5.5 | 5.5 |